Grant: Discovery Grants Program - Individual
University of Victoria
$37,050.00
Synthesis and evaluation of natural product and designed modulators of protein-protein interactions
FY 2009-10
Summary
My research group is focused on the synthesis of complex molecules that inhibit, activate, or detect protein-protein interactions. Ultimately, the tools we create in the laboratory will lead to the development of entirely new classes of medicines to treat cancer, HIV/AIDS, and a host of other diseases.
The human genome contains around 25,000 genes which encode approximately 100,000 proteins. To a large extent, humankind's ability to create effective new medicines may be equated with our ability to design (or find in Nature) molecules which bind to proteins and control their function.
Enzymes are proteins that catalyze biochemical reactions. The traditional "lock-and-key" approach to medicinal chemistry involves building molecules that fit inside an enzyme's active site, blocking access to the enzyme's natural substrate and inhibiting the particular biochemical pathway required for progression of a disease. Closely related strategies involve creating molecules that bind at a different point on the protein's three-dimensional surface and either increase or decrease access to the active site.
Many proteins exert their function by taking part in the formation of multi-protein complexes. Certain protein-protein complexes are implicated in the progression of specific diseases (cancer, HIV, malaria, etc.) of widespread importance. Unfortunately, there has been limited progress in developing molecules that selectively block the formation of undesirable protein complexes. In my group, we will develop new classes of molecules that selectively disrupt certain key protein-protein interactions, even in cases where the individual proteins lack a traditional enzyme active site. Some of our molecules will be based upon compounds isolated from Nature, while others will be designed by us for a specific purpose.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
355466-2008
Name nom
Wulff, Jeremy
Department département
Chemistry
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
37050
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
2
Nb partie
3
Application title
Synthesis and evaluation of natural product and designed modulators of protein-protein interactions
Keyword
NA
Application summary
My research group is focused on the synthesis of complex molecules that inhibit, activate, or detect protein-protein interactions. Ultimately, the tools we create in the laboratory will lead to the development of entirely new classes of medicines to treat cancer, HIV/AIDS, and a host of other diseases.
The human genome contains around 25,000 genes which encode approximately 100,000 proteins. To a large extent, humankind's ability to create effective new medicines may be equated with our ability to design (or find in Nature) molecules which bind to proteins and control their function.
Enzymes are proteins that catalyze biochemical reactions. The traditional "lock-and-key" approach to medicinal chemistry involves building molecules that fit inside an enzyme's active site, blocking access to the enzyme's natural substrate and inhibiting the particular biochemical pathway required for progression of a disease. Closely related strategies involve creating molecules that bind at a different point on the protein's three-dimensional surface and either increase or decrease access to the active site.
Many proteins exert their function by taking part in the formation of multi-protein complexes. Certain protein-protein complexes are implicated in the progression of specific diseases (cancer, HIV, malaria, etc.) of widespread importance. Unfortunately, there has been limited progress in developing molecules that selectively block the formation of undesirable protein complexes. In my group, we will develop new classes of molecules that selectively disrupt certain key protein-protein interactions, even in cases where the individual proteins lack a traditional enzyme active site. Some of our molecules will be based upon compounds isolated from Nature, while others will be designed by us for a specific purpose.